Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

DoJ creates Prescription Interdiction & Litigation Task Force

Jaclyn Jaeger | February 28, 2018

The Department of Justice has established a Prescription Interdiction & Litigation Task Force to deploy and coordinate criminal and civil law enforcement tools to tackle the opioid epidemic, with a particular focus on opioid manufacturers and distributors.

“Over the past year, the Department has vigorously fought the prescription opioid crisis, and we are determined to continue making progress,” said Attorney General Jeff Sessions.

The PIL Task Force will include senior officials from the offices of the Attorney General, the Deputy Attorney General, and the Associate Attorney General, as well as senior officials from the Executive Office for U.S. Attorneys, the Civil Division, the Criminal Division, and the Drug Enforcement Administration. The Task Force will coordinate the Department’s many efforts and tools to combat the opioid epidemic.

The PIL Task Force will combat the opioid crisis at every level of the distribution system.  At the manufacturer level...

Buy this article for $49, or subscribe to Compliance Week for a month at $149 and get unlimited article access for 30 days.